Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: A case report

Pediatric Hematology and Oncology

Volumn 20, Issue 2, 2003, Pages 161-165

  Schiavetti, Amalia ^a   De Pasquale, M D ^a   Di Salvo, S ^a   Ventriglia, F ^a   Clerico, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Congestive heart failure; Hepatic hemangiomatosis; Interferon 2a

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON;

ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DYSPNEA; FEMALE; HEMANGIOMATOSIS; HEPATOMEGALY; HUMAN; LIVER TUMOR; MEDICAL EXAMINATION; NEWBORN; SKIN HEMANGIOMA; SYSTOLIC HEART MURMUR; TACHYCARDIA; TREATMENT OUTCOME; TUMOR REGRESSION;

ABDOMINAL NEOPLASMS; ANGIOGENESIS INHIBITORS; DIGITALIS GLYCOSIDES; DIURETICS; DYSPNEA; FEMALE; FUROSEMIDE; HEAD AND NECK NEOPLASMS; HEART FAILURE, CONGESTIVE; HEART SEPTAL DEFECTS, ATRIAL; HEEL; HEMANGIOMA; HEMANGIOMA, CAPILLARY; HEMANGIOMA, CAVERNOUS; HEPATOMEGALY; HUMANS; INFANT; INTERFERON ALFA-2A; KNEE; LIVER NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; REMISSION INDUCTION;

EID: 0037367844     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/0880010390158676     Document Type: Article

References (13)

1. Stratte EG, Tope WD,Johnson CL, et al. Multimodal management of diffuse neonatal hemangiomatosis. J Am Acad Dermatol. 1996;34:337-342.
2. Baron S, Tyring SK, Fleischmann WR Jr, et al. The interferons. Mechanisms of action and clinical applications. JAMA. 1991;266:1375-1383.
3. Le Luyer B, Duquenoy A, Poinsot J, et al. Use of interferon in a case of hepatic hemangioma. Arch Pediatr. 2000;7:1201-1204.
4. Ezekowitz A, Mulliken J, Folkman J. Interferon alpha therapy of haemangiomas in newborns and infants. Br J Haematol. 1991;79:67-68.
5. White CW, Wolf SJ, Korones DN, et al. Treatment of childhood angiomatous disease with recombinant interferon alfa-2a. J Pediatr. 1991;118:59-66.
6. Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol. 1997;19:237-244.
7. Castello MA, Ragni G, Antimi A, et al. Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma. Med Pediatr Oncol. 1997;28:213-215.
8. Deb G, Donfrancesco A, Hari I, et al. Hemangioendothelioma: successful therapy with interferon-α: a study in association with the Italian Pediatric Hematology/Oncology Society (AIEOP). Med Pediatr Oncol. 2002;38:118-119.
9. Shannon K, Buchanan GR, Votteler TP. Multiple hepatic hemangiomas: failure of corticosteroid therapy and successful hepatic artery ligation. Am J Dis Child. 1982;136:275-276.
10. Hurvitz SA, Hurvitz CH, Sloninsky L, et al. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol. 2000;22:527-532.
11. Rotman M, John M, Stowe S, et al. Radiation treatment of pediatric hepatic hemangiomatosis and coexisting cardiac failure. N Engl J Med. 1980;302:852.
12. Samuel M, Spitz L. Infantile hepatic hemangioendothelioma: the role of surgery. J Pediatr Surg. 1995;30:1425-1429.
13. Fok TF, Chan MS, Metreweli C, et al. Hepatic hemangioendothelioma presenting with early heart failure in a newborn: treatment with hepatic artery embolization and interferon. Acta Paediatr. 1996;85:1373-1375.